Circulating cancer cells and their clinical applications

Clinical Chemistry

Volumn 57, Issue 11, 2011, Pages 1478-1484

  Diamandis, Eleftherios P ^a,b   Pantel, Klaus ^c   Scher, Howard I ^d   Terstappen, Leon ^e   Lianidou, Evi ^f  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY OF TWENTE   (Netherlands)

^f UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ANALYTIC METHOD; BIOPSY; BREAST CANCER; CIRCULATING TUMOR CELL; CLINICAL RESEARCH; COLON CANCER; DENSITY GRADIENT CENTRIFUGATION; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; EPITHELIAL IMMUNOSPOT ASSAY; FILTRATION; HUMAN; IMMUNOASSAY; IMMUNOCYTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; NOTE; PLASTICITY; PROGNOSIS; PROSTATE CANCER; QUALITY CONTROL; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL COUNT; HUMANS; IMMUNOHISTOCHEMISTRY; INDIVIDUALIZED MEDICINE; NEOPLASM, RESIDUAL; NEOPLASTIC CELLS, CIRCULATING; QUALITY CONTROL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 80055090760     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.166678     Document Type: Note

References (0)